Dimethyl Fumarate DR Presolicitation

Amendment / Modification

• Option 1 is exercised, effective for the period of October 28, 2023, through October 27, 2024.

• Section 1 (likely referring to a previous option period or contract section) is modified to reflect the exercised option.

• All other terms and conditions remain unchanged. This modification primarily extends the contract period based on a previously offered option.

Amendment / Modification

• The closing date for the solicitation has been extended.

• Original closing date: September 14, 2021, 3:00 PM EST

• New closing date: October 14, 2021, 3:00 PM EST

• Solicitation closing date and time.

• The deadline for proposal or quote submissions has been extended to October 14, 2021, 3:00 PM EST.

Amendment / Modification

• This amendment (0002) corrects the Offer Due Date/Local Time on page 1 of Amendment 0001.

• The Offer Due Date is corrected to September 14, 2021, at 3:00 PM EDT.

• Page 1, Block 8 (Offer Due Date/Local Time) of Amendment 0001.

• The proposal submission deadline has been clarified to September 14, 2021, at 3:00 PM EDT.

Amendment / Modification

• Amendment 0001 corrects the Solicitation Issue Date in Block 6 on page 1 from 7/8/2021 to 8/11/2021.

• Amendment 0001 corrects the Offer Due Date/Local Time in Block 8 on page 1 from 8/9/2021 3:00 PM EDT to 9/14/2021 3:00 PM EDT.

• Solicitation Issue Date (Block 6, Page 1)

• Offer Due Date/Local Time (Block 8, Page 1)

• The Offer Due Date has been extended to 9/14/2021 at 3:00 PM EDT.

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of Dimethyl Fumarate DR 120 MG (14 count bottles) and Dimethyl Fumarate DR 240 MG (60 count bottles) to the Defense Logistics Agency (DLA) through its Pharmaceutical Prime Vendor (PPV) program. The objective is to establish a national supply source for these drugs, ensuring availability, consistency, and volume-based pricing.

• Procurement of Dimethyl Fumarate DR 120 MG and 240 MG.

• Products must be compatible with automated dispensing units (e.g., Baxter ATC Canisters, OptiFill).

• Unit of use packaging must include a child-proof closure and a bottle with a minimum 100cc volume, cylindrical body, and 5.75" circumference.

• Bar code labeling at the unit-of-use package level is required, conforming to GS1-128 or HIBC standards.

• Products must be FDA approved with an acceptable cGMP status for manufacturing facilities.

• Offerors must provide product information registered with RXNorm, First Data Bank, and Medispan.

• Contract type: Firm-fixed-price.

• Period of Performance: One base year with four option years, for a maximum of five years.

• Contract Performance Date: 45 days after award.

• Pricing Effective Date: 15 days after contract performance date.

• Estimated quantities are provided in Appendix B.

• Offers must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS).

• Offer Due Date: September 14, 2021, 3:00 PM EDT.

• Evaluation criteria: Lowest Price Technically Acceptable (LPTA).

• Proposals must include a Non-Price Proposal (SF 1449, Trade Agreements, Representations and Certifications, Subcontracting Plan if applicable, Letter of Commitment/Certification) and a Price Proposal.

• A reverse auction may be utilized for price negotiations.

• The acquisition is listed as "UNRESTRICTED" but includes various small business set-aside indicators.

• NAICS Code: 325412, Size Standard: 1250 Employees.

• The contract awardee must reach business-to-business agreements with DLA PPV contractors.

• Payments will be received from PPV contractors, not directly from the Government.

• A 0.5% cost recovery fee is embedded in offered prices.